CA2453531A1 - Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells - Google Patents
Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells Download PDFInfo
- Publication number
- CA2453531A1 CA2453531A1 CA002453531A CA2453531A CA2453531A1 CA 2453531 A1 CA2453531 A1 CA 2453531A1 CA 002453531 A CA002453531 A CA 002453531A CA 2453531 A CA2453531 A CA 2453531A CA 2453531 A1 CA2453531 A1 CA 2453531A1
- Authority
- CA
- Canada
- Prior art keywords
- cells
- hematopoietic cells
- hematopoietic
- composition
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1132—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against retroviridae, e.g. HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/12—Type of nucleic acid catalytic nucleic acids, e.g. ribozymes
- C12N2310/121—Hammerhead
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- AIDS & HIV (AREA)
- Veterinary Medicine (AREA)
- Plant Pathology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30412701P | 2001-07-10 | 2001-07-10 | |
| US30428301P | 2001-07-10 | 2001-07-10 | |
| US60/304,127 | 2001-07-10 | ||
| US60/304,283 | 2001-07-10 | ||
| US34348401P | 2001-12-21 | 2001-12-21 | |
| US60/343,484 | 2001-12-21 | ||
| US38606302P | 2002-06-04 | 2002-06-04 | |
| US60/386,063 | 2002-06-04 | ||
| PCT/US2002/021907 WO2003006691A1 (en) | 2001-07-10 | 2002-07-10 | Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2453531A1 true CA2453531A1 (en) | 2003-01-23 |
Family
ID=27501852
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002453531A Abandoned CA2453531A1 (en) | 2001-07-10 | 2002-07-10 | Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US7345025B2 (cg-RX-API-DMAC7.html) |
| EP (2) | EP1414996B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP5179697B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101015913B1 (cg-RX-API-DMAC7.html) |
| CN (2) | CN101926824A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE490322T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002316640C1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR0211079A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2453531A1 (cg-RX-API-DMAC7.html) |
| DE (1) | DE60238486D1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1414996T3 (cg-RX-API-DMAC7.html) |
| IL (2) | IL159637A0 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04000268A (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ530624A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003006691A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020058636A1 (en) * | 1994-09-21 | 2002-05-16 | Geoffrey P. Symonds | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| CA2279669A1 (en) * | 1995-12-15 | 1997-06-16 | Enzo Therapeutics, Inc. | Property effecting and/or property exhibiting constructs for the expression of non-native nucleic acid processing components for therapeutic and diagnostic uses |
| US6627442B1 (en) * | 2000-08-31 | 2003-09-30 | Virxsys Corporation | Methods for stable transduction of cells with hiv-derived viral vectors |
| BR0211079A (pt) | 2001-07-10 | 2005-08-30 | Johnson & Johnson Res Pty Ltd | Processos para a modificação genética de células hematopoiéticas progenitoras e empregos das células modificadas |
| CN1551728A (zh) * | 2001-07-10 | 2004-12-01 | J&J�о��ع�����˾ | 转导造血祖细胞的生成 |
| US7994144B2 (en) * | 2001-07-10 | 2011-08-09 | Johnson & Johnson Research Pty, Limited | Process for the preparation of a composition of genetically modified hematopoietic progenitor cells |
| US7737124B2 (en) | 2001-09-13 | 2010-06-15 | California Institute Of Technology | Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell |
| CA2457282C (en) | 2001-09-13 | 2015-01-13 | California Institute Of Technology | Method for expression of small antiviral rna molecules within a cell |
| DE10212892A1 (de) * | 2002-03-20 | 2003-10-09 | Basf Plant Science Gmbh | Konstrukte und Verfahren zur Regulation der Genexpression |
| DE10224750A1 (de) | 2002-06-04 | 2003-12-24 | Fresenius Medical Care De Gmbh | Vorrichtung zur Behandlung einer medizinischen Flüssigkeit |
| WO2004071418A2 (en) * | 2003-02-06 | 2004-08-26 | Walter Reed Army Institute Of Research | Compounds for the treatment of systemic lupus erythematosus |
| JP4865541B2 (ja) * | 2003-04-08 | 2012-02-01 | イエダ リサーチ アンド ディベロップメント カンパニー リミテッド | 化学誘引物質に対する増大させた感受性を有する幹細胞およびそれを産生および使用する方法 |
| GB0410130D0 (en) * | 2004-05-06 | 2004-06-09 | Molmed Spa | Cell preparation |
| US7935074B2 (en) * | 2005-02-28 | 2011-05-03 | Fresenius Medical Care Holdings, Inc. | Cassette system for peritoneal dialysis machine |
| US8197231B2 (en) | 2005-07-13 | 2012-06-12 | Purity Solutions Llc | Diaphragm pump and related methods |
| US20070041948A1 (en) * | 2005-07-20 | 2007-02-22 | Seoul National University Industry Foundation | Method for culturing and proliferating hematopoietic stem cells and progenitor cells using human endometrial cells |
| EP2489728A1 (en) * | 2006-06-15 | 2012-08-22 | Neostem, Inc | Processing procedure for peripheral blood stem cells |
| JP2011160661A (ja) * | 2008-06-02 | 2011-08-25 | Kyowa Hakko Kirin Co Ltd | 血球細胞の初期化法 |
| US8112365B2 (en) * | 2008-12-19 | 2012-02-07 | Foster Scott C | System and method for online employment recruiting and evaluation |
| US20100210989A1 (en) | 2008-12-23 | 2010-08-19 | Janet Lesley Macpherson | Processing blood |
| US8192401B2 (en) * | 2009-03-20 | 2012-06-05 | Fresenius Medical Care Holdings, Inc. | Medical fluid pump systems and related components and methods |
| CN102438631A (zh) * | 2009-04-09 | 2012-05-02 | 史坦赛特股份有限公司 | 抗hiv干细胞及其用途 |
| WO2011008858A1 (en) | 2009-07-15 | 2011-01-20 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassettes and related systems and methods |
| US8720913B2 (en) | 2009-08-11 | 2014-05-13 | Fresenius Medical Care Holdings, Inc. | Portable peritoneal dialysis carts and related systems |
| EP2647697B1 (en) | 2010-12-01 | 2016-08-24 | Nissan Chemical Industries, Ltd. | Method for producing hematopoietic stem cells using pyrazole compound |
| DE102010053973A1 (de) | 2010-12-09 | 2012-06-14 | Fresenius Medical Care Deutschland Gmbh | Medizinisches Gerät mit einer Heizung |
| US9694125B2 (en) | 2010-12-20 | 2017-07-04 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassettes and related systems and methods |
| US9624915B2 (en) | 2011-03-09 | 2017-04-18 | Fresenius Medical Care Holdings, Inc. | Medical fluid delivery sets and related systems and methods |
| CN103648540B (zh) | 2011-04-21 | 2016-06-01 | 弗雷塞尼斯医疗保健控股公司 | 医疗流体泵送系统及相关装置和方法 |
| US9186449B2 (en) | 2011-11-01 | 2015-11-17 | Fresenius Medical Care Holdings, Inc. | Dialysis machine support assemblies and related systems and methods |
| US9610392B2 (en) | 2012-06-08 | 2017-04-04 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassettes and related systems and methods |
| US9500188B2 (en) | 2012-06-11 | 2016-11-22 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassettes and related systems and methods |
| KR102241962B1 (ko) * | 2012-09-07 | 2021-04-20 | 예일 유니버시티 | 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법 |
| DK4389764T3 (da) * | 2012-11-05 | 2026-04-13 | Regeneron Pharma | Genetisk modificerede gnavere og fremgangsmåder til anvendelse heraf |
| CA2893962C (en) * | 2012-12-06 | 2021-04-06 | Enlivex Therapeutics Ltd | Therapeutic apoptotic cell preparations, method for producing same and uses thereof |
| US9561323B2 (en) | 2013-03-14 | 2017-02-07 | Fresenius Medical Care Holdings, Inc. | Medical fluid cassette leak detection methods and devices |
| US10117985B2 (en) | 2013-08-21 | 2018-11-06 | Fresenius Medical Care Holdings, Inc. | Determining a volume of medical fluid pumped into or out of a medical fluid cassette |
| CN103471896A (zh) * | 2013-09-09 | 2013-12-25 | 上海兰卫临床检验有限公司 | 革兰染色液质控品制备方法 |
| EP3615044A4 (en) * | 2017-04-27 | 2021-01-20 | Fred Hutchinson Cancer Research Center | THERAPEUTIC FORMULAS CONTAINING CD34 + STEM CELLS DERIVED FROM NEGATIVE SELECTION |
| JP7568507B2 (ja) * | 2017-11-15 | 2024-10-16 | ウィヤード・サイエンス・エルエルシー | 非骨髄破壊的な骨髄再構成のための方法および組成物 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5254678A (en) | 1987-12-15 | 1993-10-19 | Gene Shears Pty. Limited | Ribozymes |
| ATE115999T1 (de) | 1987-12-15 | 1995-01-15 | Gene Shears Pty Ltd | Ribozyme. |
| US5866701A (en) | 1988-09-20 | 1999-02-02 | The Board Of Regents For Northern Illinois University Of Dekalb | HIV targeted hairpin ribozymes |
| US4978514A (en) | 1989-09-12 | 1990-12-18 | Fuel Tech, Inc. | Combined catalytic/non-catalytic process for nitrogen oxides reduction |
| US5225337A (en) | 1989-09-25 | 1993-07-06 | Innovir Laboratories, Inc. | Ribozyme compositions and methods for use |
| US5500357A (en) | 1990-11-02 | 1996-03-19 | Agency Of Industrial Science & Technology, Ministry Of International Trade & Industry | RNA transcription system using novel ribozyme |
| EP0578776A4 (en) | 1991-04-05 | 1995-04-12 | Edison Animal Biotech Center | INHIBITION OF A RETROVIRUS USING NON-ENCODING NUCLEIC ACIDS HYBRIDIZING ON ENCAPSIDATION SEQUENCES. |
| US5525468A (en) | 1992-05-14 | 1996-06-11 | Ribozyme Pharmaceuticals, Inc. | Assay for Ribozyme target site |
| US5693535A (en) | 1992-05-14 | 1997-12-02 | Ribozyme Pharmaceuticals, Inc. | HIV targeted ribozymes |
| US5911983A (en) | 1992-06-26 | 1999-06-15 | University Of Pittsburgh | Gene therapy for Gaucher disease using retroviral vectors |
| HUT71929A (en) | 1992-06-29 | 1996-02-28 | Gene Shears Pty Ltd | Nucleic acids and methods of use thereof for controlling viral pathogens |
| DE69333930T8 (de) | 1993-01-22 | 2007-02-22 | The Regents Of The University Of Colorado, Boulder | Lokalisierung von therapeutischen mitteln |
| IL108719A0 (en) | 1993-02-25 | 1994-08-26 | Ortho Pharma Corp | Expression constructs containing hiv inhibitory antisense and other nucleotide sequences, retroviralvectors and recombinant retroviruses containing them |
| WO1995004818A1 (en) | 1993-08-06 | 1995-02-16 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for inhibiting human immunodeficiency virus replication |
| US5624803A (en) * | 1993-10-14 | 1997-04-29 | The Regents Of The University Of California | In vivo oligonucleotide generator, and methods of testing the binding affinity of triplex forming oligonucleotides derived therefrom |
| WO1995018854A1 (en) | 1994-01-05 | 1995-07-13 | Gene Shears Pty., Ltd. | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| US5712384A (en) | 1994-01-05 | 1998-01-27 | Gene Shears Pty Ltd. | Ribozymes targeting retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| US20020058636A1 (en) | 1994-09-21 | 2002-05-16 | Geoffrey P. Symonds | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs |
| JPH11514209A (ja) | 1995-04-20 | 1999-12-07 | カイロン コーポレイション | 組換えレトロウイルス調製物による造血幹細胞の高効率エクスビボ形質導入 |
| US5741706A (en) * | 1996-06-13 | 1998-04-21 | Immusol, Incorporated | Anti-HIV ribozymes |
| TWI239352B (en) | 1997-07-23 | 2005-09-11 | Takara Bio Inc | Gene transfer method with the use of serum-free medium |
| US6506559B1 (en) * | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| US6060317A (en) | 1998-08-11 | 2000-05-09 | The United States Of America As Represented By The Department Of Health And Human Services | Method of transducing mammalian cells, and products related thereto |
| AU2036700A (en) * | 1998-12-04 | 2000-06-26 | City Of Hope | A method of genetically modifying very primitive quiescent human hematopoietic stem cells |
| WO2000075291A2 (en) * | 1999-06-08 | 2000-12-14 | Novartis Ag | Cells with enforced expression of bcl-xl |
| JP2004509120A (ja) | 2000-09-13 | 2004-03-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | カスパーゼ阻害剤およびそれらの用途 |
| JP2004532616A (ja) | 2000-12-28 | 2004-10-28 | ジョンソン・アンド・ジョンソン・リサーチ・ピー・ティー・ワイ・リミテッド | 二本鎖rna仲介遺伝子抑制 |
| CN1551728A (zh) * | 2001-07-10 | 2004-12-01 | J&J�о��ع�����˾ | 转导造血祖细胞的生成 |
| BR0211079A (pt) | 2001-07-10 | 2005-08-30 | Johnson & Johnson Res Pty Ltd | Processos para a modificação genética de células hematopoiéticas progenitoras e empregos das células modificadas |
| US7994144B2 (en) | 2001-07-10 | 2011-08-09 | Johnson & Johnson Research Pty, Limited | Process for the preparation of a composition of genetically modified hematopoietic progenitor cells |
| KR100646702B1 (ko) * | 2001-08-16 | 2006-11-17 | 에스케이씨 주식회사 | 홀 및/또는 그루브로 형성된 화학적 기계적 연마패드 |
-
2002
- 2002-07-10 BR BR0211079-2A patent/BR0211079A/pt not_active IP Right Cessation
- 2002-07-10 JP JP2003512448A patent/JP5179697B2/ja not_active Expired - Fee Related
- 2002-07-10 KR KR1020047000421A patent/KR101015913B1/ko not_active Expired - Fee Related
- 2002-07-10 DE DE60238486T patent/DE60238486D1/de not_active Expired - Lifetime
- 2002-07-10 EP EP02746963A patent/EP1414996B1/en not_active Expired - Lifetime
- 2002-07-10 CN CN2010102736257A patent/CN101926824A/zh active Pending
- 2002-07-10 WO PCT/US2002/021907 patent/WO2003006691A1/en not_active Ceased
- 2002-07-10 MX MXPA04000268A patent/MXPA04000268A/es active IP Right Grant
- 2002-07-10 CA CA002453531A patent/CA2453531A1/en not_active Abandoned
- 2002-07-10 AT AT02746963T patent/ATE490322T1/de not_active IP Right Cessation
- 2002-07-10 NZ NZ530624A patent/NZ530624A/en not_active IP Right Cessation
- 2002-07-10 US US10/192,980 patent/US7345025B2/en not_active Expired - Fee Related
- 2002-07-10 CN CNA028177428A patent/CN1553963A/zh active Pending
- 2002-07-10 AU AU2002316640A patent/AU2002316640C1/en not_active Ceased
- 2002-07-10 EP EP10183035A patent/EP2322618A1/en not_active Withdrawn
- 2002-07-10 DK DK02746963.4T patent/DK1414996T3/da active
- 2002-07-10 IL IL15963702A patent/IL159637A0/xx unknown
-
2003
- 2003-12-29 IL IL159637A patent/IL159637A/en not_active IP Right Cessation
-
2006
- 2006-08-18 US US11/506,722 patent/US7776595B2/en not_active Expired - Fee Related
-
2009
- 2009-09-14 JP JP2009211662A patent/JP2010077125A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010077125A (ja) | 2010-04-08 |
| KR20040032852A (ko) | 2004-04-17 |
| IL159637A0 (en) | 2004-06-01 |
| CN1553963A (zh) | 2004-12-08 |
| ATE490322T1 (de) | 2010-12-15 |
| EP2322618A1 (en) | 2011-05-18 |
| EP1414996A1 (en) | 2004-05-06 |
| EP1414996A4 (en) | 2007-03-28 |
| DK1414996T3 (da) | 2011-03-21 |
| US20080044394A1 (en) | 2008-02-21 |
| JP5179697B2 (ja) | 2013-04-10 |
| US7345025B2 (en) | 2008-03-18 |
| EP1414996B1 (en) | 2010-12-01 |
| MXPA04000268A (es) | 2005-03-07 |
| BR0211079A (pt) | 2005-08-30 |
| HK1065074A1 (en) | 2005-02-08 |
| JP2005528319A (ja) | 2005-09-22 |
| AU2002316640C1 (en) | 2009-01-29 |
| DE60238486D1 (de) | 2011-01-13 |
| CN101926824A (zh) | 2010-12-29 |
| US7776595B2 (en) | 2010-08-17 |
| AU2002316640B2 (en) | 2008-06-12 |
| KR101015913B1 (ko) | 2011-02-23 |
| US20040072771A1 (en) | 2004-04-15 |
| NZ530624A (en) | 2009-02-28 |
| IL159637A (en) | 2013-07-31 |
| WO2003006691A1 (en) | 2003-01-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7776595B2 (en) | Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells | |
| AU2002316640A1 (en) | Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells | |
| US20130344040A1 (en) | Process for the preparation of a composition of genetically modified hematopoietic progenitor cells | |
| KR102390629B1 (ko) | 헤모글로빈병증을 치료하기 위한 조성물 및 방법 | |
| JP2022087214A (ja) | 遺伝子改変細胞を作製するウイルス法 | |
| OA10194A (en) | Ribozyme gene therapy for hiv infection and aids | |
| US12350284B2 (en) | BCL11A microRNAs for treating hemoglobinopathies | |
| Fanning et al. | Gene therapy for HIV/AIDS: the potential for a new therapeutic regimen | |
| JP2005521632A (ja) | 形質導入造血前駆細胞の生産 | |
| CA2180358A1 (en) | Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs | |
| Ngok et al. | Clinical gene therapy research utilizing ribozymes: application to the treatment of HIV/AIDS | |
| HK1065074B (en) | Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells | |
| RU2824194C2 (ru) | Способы генной модификации гемопоэтических клеток | |
| Ho et al. | Ribozyme Gene Therapy Targeting Stem Cells for Human Immunodeficiency Virus Infection | |
| AU2002320365A1 (en) | Production of transduced hematopoietic progenitor cells | |
| Trobridge et al. | Protection of Stem Cell-Derived Lymphocytes in a Primate AIDS Gene Therapy Model | |
| WO2004044226A2 (en) | Induction of cellular senescence by cdk4 disruption for tumor supression and regression |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |
Effective date: 20150202 |